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Evaluation of the Banff Criteria for the Histological Diagnosis of 
Rejection in Renal Allograft Biopsies
Ph. M.M. Dooper, A.J. Hoitsma, R.A.P. Koene, and M.J.J.T. Bogman
A HISTOLOGICAL diagnosis o f renal allograft rejec­tion can be made readily if the clearcut picture is 
present (ie, considerable interstitial infiltrate, tubular inva­
sion, and intimal arteritis1). In many cases, however, the 
histological changes are less characteristic and the differen­
tial diagnosis— especially with regard to cyclosporine (CyA) 
toxicity, borderline changes, and innocent interstitial infil­
trates— may be difficult and subject to variable interpreta­
tion.2" 6 Recently, the Banff working classification of kidney 
transplant pathology was proposed as an attempt to devise 
a schema for interpretation and gradation of the histologi­
cal findings in renal graft biopsies that can be used as an 
indication for therapeutic consequences and expected graft 
survival.7 In the Banff schema, apart from interstitial infil­
tration, tubulitis and intimal arteritis are important lesions 
indicative of acute rejection (AR). As stated by the authors, 
the usefulness of the Banff schema with regard to standard­
ization of histological criteria for rejection and clinical 
implications must be assessed by clinicopathological studies 
in larger series.7 We tested the value of the Banff criteria by 
comparing the retrospectively and blindly scored histologi­
cal diagnosis according to the Banff classification with the 
eventual clinical diagnosis.
MATERIALS AND METHODS
The clinical analysis was done in a series of 246 consecutive renal 
allograft biopsies over a period of 3 years (1988-1990). Indications 
for biopsy were graft dysfunction with an increase of creatinine 
>25% and/or proteinuria >2.5 g/24 h. The immunosuppressive 
regimen consisted of CyA and prednisone (P). CyA was started at 
a dose of 12 mg/kg and was tapered down to 5 mg/kg in the 12 
weeks following transplantation, with conversion to azathioprine in 
a dose of 3 mg/kg at 12 weeks after transplantation. P was started 
at a dose of 100 mg daily, with a gradual decrease to 25 mg daily 
during the first month, 20 mg during the second and third month, 
and then 10 mg. Core biopsies were performed using a 14-gauge 
Tru-cut needle. Histological examination was performed retrospec­
tively, without knowledge of clinical data, on 2-ju,m paraffin sections 
of Bouin’s fixed renal tissue stained with haematoxylin and eosin, 
periodic acid-Schiff, silver methenamine, and chrome aniline blue. 
Biopsies with insufficient cortical tissue were excluded as inade­
quate. The histological findings were, according to the Banff 
schema, grouped in six categories: (1) normal; (2) hyperacute 
rejection; (3) borderline changes (“very mild AR”); (4) AR, 
divided into grade 1—mild AR, grade II—moderate AR, and grade 
III—severe AR; (5) chronic allograft nephropathy (CR), grades I 
to III; and (6) other changes including CyA toxicity and acute 
tubular necrosis (ATN).7 The final clinical diagnoses were made 
retrospectively by three nephrologists based on clinical signs, 
original histological diagnosis, response to therapy, and eventual 
outcome. These clinical diagnoses were coded as (1) AR; (2) 
probable AR; (3) equivocal, or uncertain rejection combined with
Table 1. Comparison of the Final Clinical Diagnosis and the 
Banff Histological Diagnosis in 210 Renal Graft Biopsies
Clinical Diagnosis
BANFF Diagnosis No of Bx AR Prob AR Equivocal CR No R
Borderline changes 38 8 6 0 8 16
AR Grade i 30 14 2 2 2 10
Grade li/ll! 118 85 13 7 5 8
CR/CyA/ATN/other 24 1 1 0 9 13
Total 210 108 22 9 24 47
Abbreviations: Bx, biopsies; Prob AR, probable acute rejection; ATN, acute 
tubular necrosis.
other causes of graft dysfunction; (4) chronic rejection (CR); and 
(5) no rejection (no R).
RESULTS AND D ISCUSSIO N
Of a total of 246 consecutive renal allograft biopsies, 210 
(originating from 145 patients) were adequate and available 
for analysis. The time interval between biopsy and trans­
plantation varied from 1 to 308 weeks (mean 24 weeks). 
The clinical diagnoses in each Banff category are summa­
rized in Table 1. There were no biopsies with normal 
histology or with signs of hyperacute rejection.
Borderline Changes (n =  38)
Fourteen cases had a clinical diagnosis of A R  or probable 
AR, with a favorable response to antirejection therapy in 11 
cases and stabilization of moderately impaired graft func­
tion in three. Thus, the advice in the Banff classification that 
borderline changes are insufficient to justify antirejection 
treatment must be regarded with caution,
AR Grades 1 Through HI (n =  148)
The Banff diagnosis correctly identified the eventual clinical 
diagnosis in 114 cases (77%). A  combination of Banff 
diagnosis AR and a clinical diagnosis CR or no R was seen  
in 25 cases (17%). This group consisted of 12 of the 30 cases 
with grade I AR (40%) and 13 of the 118 cases with grades 
II and III AR (11%). This difference was significant (P <  
.0005; Fisher exact test). Therefore, the Banff classification
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has a tendency to overdiagnosis of AR, especially in grade
I. In nine cases (6 %) with a Banff diagnosis of AR, the 
clinical diagnosis was uncertain (equivocal). In seven of 
these, antirejection therapy was given with a favorable 
response in four cases, stabilization of renal function in two, 
and a rise of serum creatinine in one case. Of the two 
patients who did not receive antirejection therapy, one 
patient showed spontaneous recovery of graft function, 
whereas the other lost the graft after surgery for renal 
artery stenosis.
Other Histological Changes (n -  24)
A  Banff diagnosis of CR/CyA/ATN/ or other was clinically 
correct in 22 o f these cases (92%). Of the two remaining 
cases, one patient had a suspected posttranspiant lym­
phoma in his graft biopsy leading to excision of the graft 
(clinical diagnosis of AR at biopsy). The other patient had 
a histological diagnosis of combined AR and CyA toxicity. 
He died of myocardial infarction 1 day after installment of 
antirejection treatment with a lowering of the CyA dose 
(clinical diagnosis probable AR).
The data in this series suggest that the Banff schema can 
serve as an acceptable guideline for a standardized histo­
logical evaluation of renal graft biopsies. A  major problem  
in the histological diagnosis is the relative weighting of the 
respective criteria of AR, such as interstitial infiltrate and 
tubulitis. For validation of the semiquantitative grading of 
these symptoms, as suggested by Solez et al,7 it will be 
necessary to study the relative importance of the different 
qualitative and quantitative changes in large series. In 
addition, the diagnostic problems in cases with a complex of 
changes suggesting AR and CyA toxicity and/or CR remain  
unsolved.
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